본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Targeting Ovarian Neoplasms: Subtypes and Therapeutic Options Chae Chang Suk
(Cancer？Microenvironment Branch)

Seonyoung-HONG
(Department of Cancer Biomedical Science)
. Targeting Ovarian Neoplasms: Subtypes and Therapeutic Options. MEDICINA-LITHUANIA. 2025-12-18; 2025; 61(12):2246~. IF 2.4 (2024)
ULK1 knockout suppresses pancreatic cancer progression by inhibiting autophagy and enhancing antitumor immunity Cheong Heesun
(Cancer Metastasis Branch)

Jeong Ha Na
(Cancer Metastasis Branch)
. ULK1 knockout suppresses pancreatic cancer progression by inhibiting autophagy and enhancing antitumor immunity. EXPERIMENTAL AND MOLECULAR MEDICINE. 2025-12-17; 2025; :~. IF 12.9 (2024)
Novel syngeneic model of anti-mouse CLDN18.2 CAR -T therapy for gastric cancer demonstrates a synergy with TGF-β and PD-L1 inhibitors Hark Kyun Kim
(Targeted Therapy Branch)

seo min jung
(Immuno-oncology Branch)
. Novel syngeneic model of anti-mouse CLDN18.2 CAR -T therapy for gastric cancer demonstrates a synergy with TGF-β and PD-L1 inhibitors. MOLECULAR THERAPY ONCOLOGY. 2025-12-17; 2025; 34(1):201120~. IF 5.3 (2024)
Deep learning-based dose prediction for prostate cancer with empty bladder protocol: a framework for efficient and personalized radiotherapy planning Jeong Jong Hwi
(Department of Radiation oncology)


()
. Deep learning-based dose prediction for prostate cancer with empty bladder protocol: a framework for efficient and personalized radiotherapy planning. FRONTIERS IN ONCOLOGY. 2025-12-17; 2025; 15:1690416~. IF 3.3 (2024)
Feasibility of sentinel basin mapping after non-curative endoscopic resection for early gastric cancer: a prospective multicenter cohort study (SENORITA 2 trial) Eom Bang Wool
(Cancer Outcome & Quality Improvement Branch)


()
. Feasibility of sentinel basin mapping after non-curative endoscopic resection for early gastric cancer: a prospective multicenter cohort study (SENORITA 2 trial). INTERNATIONAL JOURNAL OF SURGERY. 2025-12-16; 2025; :~. IF 10.3 (2024)
Reoperation Versus Dose-Escalated Radiotherapy for Ductal Carcinoma In Situ at the Surgical Margin After Breast-Conserving Surgery for Invasive Ductal Carcinoma Lee Eun Gyeong
(Department of Surgery)


()
. Reoperation Versus Dose-Escalated Radiotherapy for Ductal Carcinoma In Situ at the Surgical Margin After Breast-Conserving Surgery for Invasive Ductal Carcinoma. JOURNAL OF BREAST CANCER. 2025-12-15; 2025; 28(6):381~392. IF 2.4 (2024)
Activation of the STING pathway potentiates the antitumor efficacy of doxorubicin in soft-tissue sarcoma Sun-Young Kong
(Targeted Therapy Branch)

lee gi yeon
(Targeted Therapy Branch)
. Activation of the STING pathway potentiates the antitumor efficacy of doxorubicin in soft-tissue sarcoma. FRONTIERS IN ONCOLOGY. 2025-12-12; 2025; 15:1634503~. IF 3.3 (2024)
Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies Kim Jung Hyun
(Cancer Metastasis Branch)

Choi Sang A
(Cancer Metastasis Branch)
. Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025-12-10; 2025; 26(24):11918~. IF 4.9 (2024)
Long-Term Cancer Incidence Trends in Korea (2001-2020): An Age-Period-Cohort and Joinpoint Analysis with a Focus on Younger Cohorts Chung Jinsoo
(Immuno-oncology Branch)

Lee Hyung Ho
(Center for Prostate Cancer)
. Long-Term Cancer Incidence Trends in Korea (2001-2020): An Age-Period-Cohort and Joinpoint Analysis with a Focus on Younger Cohorts. MEDICINA-LITHUANIA. 2025-12-08; 2025; 61(12):2179~. IF 2.4 (2024)
Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer Shim Jae Gal
(Cancer Metastasis Branch)

Sung Jee Young
(Cancer Metastasis Branch)
. Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer. JOURNAL OF TRANSLATIONAL MEDICINE. 2025-12-05; 2025; 23(1):1380~. IF 7.5 (2024)
First page Prev paging 1 2 3 4 5 6 7 8 9 10 next paging last page